Empresa Distribuidora y Comercializadora Norte Sociedad Anónima engages in the distribution and sale of electricity in Argentina. The company operates an electrical power distribution system that consists of 85 transformation substations and interconnections with high voltage customers with 20,295 MVA of installed power and 1,594 km of high voltage networks; and MV/LV and MV/MV distribution system comprises 19,845 transformers with 10,137 MVA of installed power, 12,732 km of medium voltage networks, and 28,590 km of low voltage networks. It serves approximately 3.39 million customers. The company was formerly known as Empresa Distribuidora Norte Sociedad Anónima and changed its name to Empresa Distribuidora y Comercializadora Norte Sociedad Anónima in January 1997. The company was founded in 1992 and is based in Buenos Aires, Argentina. Empresa Distribuidora y Comercializadora Norte Sociedad Anónima operates as a subsidiary of Empresa de Energía del Cono Sur S.A.…
What Empresa Distribuidora Y Comercializadora Norte S.A. (Edenor) (EDN) Said on Its Q3 Earnings Call
Empresa Distribuidora y Comercializadora Norte Sociedad Anónima (NYSE: EDN) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Utilities - Regulated Electric industry, part of the Utilities sector, and reports about 4,576 employees.
The shares were at 11.50 USD on 20 November 2026, down 62.6% over 52 weeks. Its 52-week range is 11.44 USD to 36.70 USD, and it trades at the bottom of that range.
At a market capitalisation of 547.10M USD, it trades at 2.7 times trailing earnings and 8.4 times forward earnings. The median trailing P/E of its 20 largest Utilities - Regulated Electric peers is 20.0, a discount of 87% for EDN.
Empresa Distribuidora y Comercializadora Norte Sociedad Anónima reports return on equity of 10.8%, an operating margin of 9.9% and revenue up 13.7% year over year.
Its debt exceeds its cash by 597.24B ARS, a debt-to-equity ratio of 0.54. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 2 analysts cover the stock, with an average rating of Buy; their mean price target of 37.50 USD is 226.1% above the current price. The next earnings report is expected on 5 March 2027.